Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.
about
Mucosal resident memory CD4 T cells in protection and immunopathologyGenital Herpes: Insights into Sexually Transmitted Infectious DiseaseCD4 T-cell responses to herpes simplex virus type 2 major capsid protein VP5: comparison with responses to tegument and envelope glycoproteins.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesCharacteristics of HIV target CD4 T cells collected using different sampling methods from the genital tract of HIV seronegative womenTegument-specific, virus-reactive CD4 T cells localize to the cornea in herpes simplex virus interstitial keratitis in humans.Recent progress in herpes simplex virus immunobiology and vaccine researchExpression of cutaneous lymphocyte-associated antigen and E-selectin ligand by circulating human memory CD4+ T lymphocytes specific for herpes simplex virus type 2.Homing in on the cellular immune response to HSV-2 in humans.Development of effective vaccines for old mice in a tumor model.Intravaginal Zinc Oxide Tetrapod Nanoparticles as Novel Immunoprotective Agents against Genital Herpes.Diversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.A genital tract peptide epitope vaccine targeting TLR-2 efficiently induces local and systemic CD8+ T cells and protects against herpes simplex virus type 2 challengeA Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell ImmunogensEffector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationCurrent trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.The challenge of developing a herpes simplex virus 2 vaccine.An adjuvanted herpes simplex virus 2 subunit vaccine elicits a T cell response in mice and is an effective therapeutic vaccine in Guinea pigs.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.High-level expression of glycoprotein D by a dominant-negative HSV-1 virus augments its efficacy as a vaccine against HSV-1 infection.Herpes simplex virus type 2 tegument proteins contain subdominant T-cell epitopes detectable in BALB/c mice after DNA immunization and infectionProphylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral ReseORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans.Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses Against Herpes Infection and Disease‡.
P2860
Q26823137-98C2D110-0A5B-4CF2-9AF1-A54142C53E9EQ30235026-C6751E45-3046-4F32-A4A3-7E7674511725Q30957753-CE7FAA0B-A432-4F6E-AE4F-4A3C187613DFQ33248961-25ACE447-56FC-46F5-B465-195FA0D6AE46Q33751697-8DE0142C-3086-4E30-8BAF-41DCE7A46F37Q33826410-5E8D4D27-BAE3-4D22-969C-F6A91CAC5CE2Q33963713-EC34DDCE-5EC0-4C0A-A93D-099D2BCE6A52Q34081662-4CCDA6F3-3A0C-44AD-B327-883183A6C8F2Q34081670-854DF1ED-C2C5-42B0-86B0-1839A4BEFCB3Q34501086-177DC54D-EE4A-47D7-866D-77F4EAE35238Q34526716-D2EBA630-EF56-4CD7-862F-54DF76298009Q34648449-82A26D24-1FBD-44CE-AD6B-9E3AA656C1DEQ35699002-3309FF1E-E39E-4707-BA8B-FF6EE625103BQ35854117-F396AA7D-DFE0-49CF-B842-CAAFF9372F41Q35871689-CB90B10D-7E4F-4A81-B243-6EDEB870B7E2Q35914367-7A15FF87-5328-4126-BAE5-B489B09E7630Q36237622-AE9480B7-851F-4A32-A52C-8E42E9185FBCQ36555158-BACECEC3-DA5A-4877-985A-9E2298AB3565Q36671106-33C7E3A1-1BA7-448F-BB15-EA5C39FBA4CAQ36759693-944C9298-6C34-4CDC-AFA5-B0B4EE6DD96EQ36898071-8EDC0AC2-C31E-4D8A-96E1-4279BFCB8036Q37160338-CCE273C7-8D47-47EC-8620-4C6E30AC58E1Q37174520-957B0ACF-4B4B-4348-A4B0-D43A81ADEF90Q38947443-BFC32CFB-5089-4CB0-B729-E845B166813EQ41848044-156D8C17-AEE8-4965-8CCB-6B9CF49B124FQ50043299-3D101936-B9D2-474D-A8C1-E2BC7D69B587
P2860
Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Recognition of herpes simplex ...... human genital herpes lesions.
@en
Recognition of herpes simplex ...... human genital herpes lesions.
@nl
type
label
Recognition of herpes simplex ...... human genital herpes lesions.
@en
Recognition of herpes simplex ...... human genital herpes lesions.
@nl
prefLabel
Recognition of herpes simplex ...... human genital herpes lesions.
@en
Recognition of herpes simplex ...... human genital herpes lesions.
@nl
P2093
P2860
P1433
P1476
Recognition of herpes simplex ...... human genital herpes lesions.
@en
P2093
P2860
P304
P407
P577
1998-09-01T00:00:00Z